Janux Therapeutics Stock Predictions

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Sell

JANX
Janux Therapeutics

Last Price:

$25.27

Seasonality Move:

-6.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Janux Therapeutics Stock Forecast

Over the next 52 weeks, Janux Therapeutics has on average historically risen by 102.8% based on the past 3 years of stock performance.
Janux Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Is Janux Therapeutics Stock Undervalued?

The current Janux Therapeutics [JANX] share price is $26.06. The Score for JANX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Janux Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Janux Therapeutics has on average historically risen by 102.8% based on the past 3 years of stock performance.

Janux Therapeutics Stock Rating

Sell

Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics overpriced?

Janux Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Janux Therapeutics Stock Price History

Is JANX stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

januxrx.com

52-Week Data

52-Week High:

71.71

52-Week Low:

22.52

Prediction Charts

Market Cap:

1.5B

Price in USD:

26.06

Volume:

1.5M

Beta:

3.31

Technical Analysis

SMA50:

29.48

SMA100:

37.69

SMA200:

42.79

52-Wk Change:

-46.73%

Stock Predictions

Is Janux Therapeutics stock public?

Yes, Janux Therapeutics is a publicly traded company.
What is the Janux Therapeutics stock quote today?

The Janux Therapeutics stock price is 26.06 USD today.
How to buy Janux Therapeutics stock online?

You can buy Janux Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-23	31.03	31.62	32.59	30.62
Apr-24	31.47	32.07	32.09	30.87
Apr-25	31.49	31.05	31.92	30.20
Apr-28	31.41	32.23	32.38	31.20
Apr-29	32.09	32.55	32.70	31.42
Apr-30	31.99	33.20	33.51	31.78
May-1	32.40	32.05	33.09	31.34
May-2	32.40	32.88	33.97	32.05
May-5	30.00	29.79	31.39	29.23
May-6	29.49	25.54	29.82	25.01
May-7	25.62	25.70	26.40	24.80
May-8	25.74	26.37	26.87	24.13
May-9	26.25	25.56	28.13	25.44
May-12	26.51	26.06	27.17	25.36

Janux Therapeutics Earnings

Janux Therapeutics Earnings Report: Per Share Janux Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Janux Therapeutics Forecast Revenue Growth

Janux Therapeutics Stock Analysis: Historical quarterly revenues per share for Janux Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.30 per share, a decrease this year of $0.81 per share, and a decrease next year of $0.71 per share.

* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.